Seeing Is Believing
Currently out of the existing stock ratings of Bruce D. Jackson, 11 are a BUY (100%).
Analyst Bruce D. Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 28.57% that have a potential upside of 65.47% achieved within 332 days.
Bruce D. Jackson’s has documented 18 price targets and ratings displayed on 2 stocks.
Most recent stock forecast was given on UNCY, Unicycive Therapeutics at 01-Jul-2026.
Analyst best performing recommendations are on UNCY (UNICYCIVE THERAPEUTICS).
The best stock recommendation documented was for UNCY (UNICYCIVE THERAPEUTICS) at 8/17/2021. The price target of $13 was fulfilled within 183 days with a profit of $12.6 (49.22%) receiving and performance score of 2.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Feb-2024
$50
$44.27 (772.60%)
$6
7 days ago
(01-Jul-2026)
2/3 (66.67%)
$44.72 (846.97%)
87
Buy Since 17-Aug-2021
$13
$7.27 (126.88%)
$18
7 days ago
(01-Jul-2026)
2/7 (28.57%)
$7.72 (146.21%)
332
Buy Since 17-Aug-2021
$15
$8.37 (126.24%)
$21
3 months 2 days ago
(06-Apr-2026)
2/5 (40%)
$8.38 (126.59%)
332
Buy Since 09-Aug-2021
$63
$55.87 (783.59%)
7 months 26 days ago
(12-Nov-2025)
1/4 (25%)
$57.86 (1125.68%)
177
Buy Since 08-Jun-2022
$22
$14.87 (208.56%)
$7.5
8 months 9 days ago
(29-Oct-2025)
3/8 (37.5%)
$17.2 (358.33%)
44
Which stock is Bruce D. Jackson is most bullish on?
What Year was the first public recommendation made by Bruce D. Jackson?